Study on the effect of the treatment of Periplaneta americana L. extract Ento-B by Dinitrochlorobenzene combined with acetic acid induced UC in rats.
Journal
Acta cirurgica brasileira
ISSN: 1678-2674
Titre abrégé: Acta Cir Bras
Pays: Brazil
ID NLM: 9103983
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
09
2020
accepted:
02
12
2020
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
To study the Periplaneta americana L. extract Ento-B on the treatment of chronic ulcerative colitis induced by 2,4-dinitrochlorobenzene and acetic acid in rats and to explore its primary mechanism of action. Using 2,4-dinitrochlorobenzene combined with acetic acid to induce chronic ulcerative colitis (chronic UC) in rats. The sulfasalazine (400 mg/kg) and Ento-B (200 mg/kg, 100 mg/kg,50 mg/kg) were given by intragastric administration and the effect was evaluated according to the disease activity index (DAI) score, colon mucosal injury index (CMDI) score, histopathological score (HS) and the serum levels of Interleukin-4(IL-4), Interleukin-10(IL-10), Tumor necrosis factor-α(TNF-α), Malondialdehyde(MDA), Superoxide dismutase(SOD) and Inducible nitric oxide synthase(iNOS.). Compared with the model group, all doses of Ento-B could reduce the score of CMDI (p < 0.05), HS(p < 0.05 or p < 0.01), significantly increased the expression of IL-4, IL-10, SOD (p < 0.01) and decreased the levels of TNF-α, MDA, iNOS in serum of UC rats, significantly improving the degree of colon lesionsin UC rats. Ento-B may play an important role in the treatment of ulcerative colitis induced byUC rats. The mechanism may be related to the increased expression of IL-4, IL-10, SOD and reduced expression of TNF-α, MDA, iNOS.
Identifiants
pubmed: 33605307
pii: S0102-86502021000100204
doi: 10.1590/ACB360102
pmc: PMC7892194
pii:
doi:
Substances chimiques
Dinitrochlorobenzene
0
Plant Extracts
0
Tumor Necrosis Factor-alpha
0
Acetic Acid
Q40Q9N063P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e360102Références
Clin Exp Immunol. 1999 Sep;117(3):462-8
pubmed: 10469048
Scand J Gastroenterol. 1998 Feb;33(2):174-9
pubmed: 9517529
Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(5):856-862
pubmed: 28994526
Yao Xue Xue Bao. 2016 Jul;51(7):1077-82
pubmed: 29897181
J Clin Pharmacol. 2007 Aug;47(8):930-41
pubmed: 17567930
Eur J Pharmacol. 2002 May 17;443(1-3):197-204
pubmed: 12044810
Zhong Yao Cai. 2013 May;36(5):707-11
pubmed: 24218957